INTRODUCTION {#sec1-1}
============

Aortic valve is a trileaflet valve which is thickened at its tips (Arantius) and allows a complete seal, while closing to avoid any back flow into the LV cavity, by overlapping neighboring leaflets by 2-3 mm. Sinuses of Valsalva are outpouching\'s behind the aortic cusps when the valve is open. The sinuses support the aortic leaflets superiorly. The sinuses provide a reservoir for diastolic blood flow to the coronary vessels RCA arises from the right anterior sinus while the LCA arises from the left posterior sinus \[[Figure 1](#F1){ref-type="fig"}\]. The right posterior sinus does not give rise to coronary artery and is called non-coronary sinus. The fibrous annulus supports the aortic cusp and is continuous with the mitral annulus as well as the mitral aortic inter Valvular ridge. Hemodynamic affections of aortic valve include aortic stenosis (AS), aortic regurgitation (AR) or both.

![Real-time echo simulation with augmented reality. (photo courtesy by CAE-DSS Imagetech)](ACA-19-498-g001){#F1}

TRANSTHORACIC ECHOCARDIOGRAPHY AND SIMULATION {#sec1-2}
=============================================

Transthoracic echocardiography (TTE) is a noninvasive and readily available diagnostic technique that is observing an increased perioperative use by anaesthesiologists. A focused, goal-directed examination can be performed in \<10 min that has been shown to alter patient management and may improve outcomes. A prospective, observational study demonstrated that a focused TTE performed by anesthesiologists resulted in alterations in the management for 84% of the patients, and the results correlated with cardiologists' formal results in 90% of the cases. Moreover, three-dimensional (3D) models allow visualization of valves from an atrial or ventricular perspective, thus offering better insight into the complex pathophysiological mechanisms responsible for the disease process.\[[@ref1]\] In the hands of a trained anesthesiologist, clinical information may be obtained quickly when sufficient time is lacking to obtain a formal TTE examination. Simulation allows interactive TTE learning using a virtual 3D model of the heart and may aid in the acquisition of the cognitive and technical skills needed to perform TTE \[[Figure 1](#F1){ref-type="fig"}\]. The ability to link probe manipulation, cardiac anatomy, and echocardiographic images using a simulator has been shown to be an effective model for training anesthesiology residents in transesophageal echocardiography. A proposed alternative to real-time reality patient-based learning is simulation-based training that allows anesthesiologists to learn complex concepts and procedures.

This module allows real-time simulated TTE imaging of the virtual heart using a mannequin. The life size mannequin torso has soft skin with accurate, palpable anatomical landmarks to aid in the positioning of the handheld ultrasound probe. The screen display allows the user to identify the position of the probe on the virtual chest as well as to see the orientation of the ultrasound plane. The anatomy display includes a representation of the chest wall, ribs, sternum, and spine as well as great vessels, lungs, pericardium, diaphragm, and liver.

As the learner scans the mannequin, the high-resolution monitor displays a realistic simulated ultrasound image beside a real-time 3D graphic representation of the anatomy, including the surrounding structures and organs \[[Figure 2](#F2){ref-type="fig"}\]. The 3D anatomy feature can be toggled on or off, or it can be customized to adapt to the learner\'s level of knowledge and ultrasound imaging skill. This augmented reality feature improves understanding of how the heart works and speeds the path to proficiency in obtaining ultrasound images. As a learner progresses, the instructor may turn off the 360° anatomical image and transform the echo simulator into an ultrasound imaging system that more closely resembles what a resident would find in a clinical setting.

![Three-dimensional echocardiography (three-dimensional)](ACA-19-498-g002){#F2}

PATHOLOGY OF SIMULATOR FOR AORTIC VALVE {#sec1-3}
=======================================

**Heart works pathology has modules** for both TTE and transesophageal echocardiogram (TEE) imaging have been created to facilitate the echocardiographic evaluation of patients with structural and hemodynamic disturbances.

This module includes:

Mechanical aortic valveAortic stenosis (AS) and mitral stenosis Doppler.

MECHANICAL AORTIC VALVE {#sec1-4}
=======================

This model demonstrates bileaflet mechanical aortic valve prosthesis. The Doppler profile permits detailed evaluation of prosthetic function while the characteristics of the left ventricle and aorta reflect the underlying native pathology, i.e. ventricular hypertrophy and poststenotic dilation of the ascending aorta \[[Figure 3](#F3){ref-type="fig"}\].

![Transesophageal echocardiogram image of mechanical aortic valve. (photo courtesy by CAE-DSS Imagetech)](ACA-19-498-g003){#F3}

BRIEF ANATOMY OF THE AORTIC VALVE {#sec1-5}
=================================

Aortic valve is a trileaflet valve which is thickened at its tips (Arantius) and allows a complete seal, while closing to avoid any back flow into the left ventricular (LV) cavity, by overlapping the neighboring leaflets by 2--3 mm.

Sinuses of Valsalva are outpouchings behind the aortic cusps when the valve is open. The sinuses support the aortic leaflets superiorly. The sinuses provide a reservoir for diastolic blood flow to the coronary vessels. The right coronary artery arises from the right anterior sinus while the left coronary artery arises from the left posterior sinus \[[Figure 4](#F4){ref-type="fig"}\]. The right posterior sinus does not give rise to coronary artery and it is called noncoronary sinus.\[[@ref2]\]

![(a-c) Aortic valve on mannequin in PSSAX, it is being trileaflet, and the left main coronary artery is originating from the left posterior sinus. The right coronary artery is shown in similar echocardiographic view being arising from the right anterior sinus. (photo courtesy by CAE-DSS Imagetech)](ACA-19-498-g004){#F4}

The fibrous annulus supports the aortic cups and it is continuous with the mitral annulus as well as the mitral aortic intervalvular ridge.

Hemodynamic affections of aortic valve include AS, aortic regurgitation (AR), or both.

Bicuspid valve {#sec2-1}
--------------

Bicuspid aortic valve is one of the most common cardiac abnormalities occurring in 1% of the population.\[[@ref3]\] It can result in AS, AR, or combined AS and AR. Usually, the AS is initially mild and progressively increases over several years \[[Figure 5](#F5){ref-type="fig"}\].

![AR on simulator in different views of aortic valve. (a and b) PSPLAX view and (c and d) apical simulated view. (photo courtesy by CAE-DSS Imagetech)](ACA-19-498-g005){#F5}

The bicuspid aortic valve is also prone to infective endocarditis (IE). A classical bicuspid valve has two aortic sinuses. However, several variations of the bicuspid aortic valve occur including an incomplete cusp called raphe. This variant usually has three aortic sinuses. The commissiornal plane dividing the cusps could be horizontal, oblique, or vertical. An "acquired" bicuspid valve sometimes results from inflammatory (rheumatic) or calcific fusion of two adjacent cusps, thus giving an appearance similar to congenital bicuspid valve.

AORTIC STENOSIS {#sec1-6}
===============

Severe AS has an extremely adverse prognosis for symptomatic patients not eligible for the standard surgical aortic valve replacement. Transcatheter aortic valve replacement (TAVR) has been emerged as a new minimally invasive treatment for such high-risk patients.\[[@ref4]\] In the case of the Edwards Sapien^®^ valve, the procedure consists of the delivery of a balloon-expandable stented tissue valve to the site of the native pathological valve via transfemoral or transapical catheterization. We hypothesize that the presence of large deposits of calcium *in situ* is a significant cause of intra- and post-procedural complications. Hence, the simulation of the deployment in the patient-specific aortic root (AR) models encompassing the patient\'s pathophysiological features may represent a valuable procedural planning tool and lead to improved design of TAVR device \[[Figure 6](#F6){ref-type="fig"}\].

![Finite element model of a patient-specific aortic root and SAPIEN® valve in midway position before deployment](ACA-19-498-g006){#F6}

INDICATION OF TRANSTHORACIC ECHOCARDIOGRAPHY IN AORTIC STENOSIS {#sec1-7}
===============================================================

Class 1 {#sec2-2}
-------

To confirm the presence and severity of ASAssessment of the LV size and functionRe-evaluation in mild/moderate AS on symptom changeRe-evaluation for the LV size/function in asymptomatic severe AS.

ETIOLOGY OF AORTIC STENOSIS {#sec1-8}
===========================

The etiology of aortic valve stenosis may be congenital (unicuspid, bicuspid, or trileaflet aortic valve with unequal cusps), rheumatic aortic valve stenosis, or sclero degenerative AS \[[Figure 7](#F7){ref-type="fig"}\]. However, other pathologies causing LV outflow tract obstruction may mimic AS that include sub-aortic membrane, hypertrophic cardiomyopathy, and supravalvular stenosis. The AS jet is usually eccentric, and therefore, multiple imaging planes are required for parallel Doppler interrogation. Usually, apical 5C, right parasternal, and high left parasternal imaging planes are utilized for optimal alignment of the Doppler beam to the direction of AS jet \[[Figure 8](#F8){ref-type="fig"}\].

![(a and b) Simulated PLAX view of aortic stenosis, depicting the reduced opening of the aortic valve. (photo courtesy by CAE-DSS Imagetech)](ACA-19-498-g007){#F7}

![Proper alignments to aortic stenosis jet for better Doppler study](ACA-19-498-g008){#F8}

CRITERIA FOR AORTIC STENOSIS {#sec1-9}
============================

In asymptomatic patients with severe AS, a closely monitored treadmill stress echo can be performed to objectively evaluate exercise capacity and to observe for any improvement in the calculated aortic valve area. In patients with significant LV dysfunction and AS, a markedly low AVA is sometimes observed together with low transvalvular gradient. This "low gradient" AS can be appropriately categorized into critical versus noncritical using dobutamine infusion to increase cardiac output in an attempt to increase the aortic valve opening \[[Table 1](#T1){ref-type="table"}\].

###### 

Quantification of aortic stenosis

  ---------------------------
  Aortic valve area (cm^2^)
   \>1.5 mild
   1-1.5 moderate
   0.75-1 moderately severe
   \<0.75 severe
  Peak gradient (mmHg\*)
   20-40 mild
   40-60 moderate
   \>60 severe
  Mean gradient (mmHg\*)
   \<20 mild
   20-40 moderate
   \>40 severe
  ---------------------------

\*At average heart rates of 70-100/min and average cardiac output

AORTIC REGURGITATION {#sec1-10}
====================

Aortic regurgitation may be the cause of diseases affecting the aorta such as dilatation and aortic dissection or may be due to pathologies of the leaflets such as congenital bicuspid valves, calcifications, myxomatous, rheumatic or IE. AR causes volume overload in LV that leads to its progressive dilatation and could lead to systolic dysfunction \[Figure [9a](#F9){ref-type="fig"} and [b](#F9){ref-type="fig"}\].

![Echocardiographic picture showing Aortic regurgitation jet on the simulator. (photo courtesy by CAE-DSS Imagetech)](ACA-19-498-g009){#F9}

Indication of transthoracic echocardiography in aortic regurgitation {#sec2-3}
--------------------------------------------------------------------

To confirm the presence and severity of ARAssessment of left ventricular size and functionRe-evaluation in mild/moderate AR on symptom change.

Assessment of regurgitation and severity of aortic dilatation in patients with enlarged AO root \[[Table 2](#T2){ref-type="table"}\].

###### 

Aortic regurgitation severity

  ------------------------------------------------------------------------
  Jet width proportional to the left ventricular outflow tract width (%)
   \<25 mild
   25-66 moderate
   \>66 severe
  Vena contracta (mm)
   \<2 mild
   3-6 moderate
   \>7 severe
  Proximal flow convergence regurgitant orifice (cm2)
   \<0.1 mild
   0.1-0.3 moderate
   \>0.3 severe
  Regurgitant fraction (%)
   \<30 mild
   30-50 moderate
   \>50 severe
  Regurgitant volume (ml)
   \<30 mild
   30-60 moderate
   \>60 severe
  Pressure half-time (m)
   \>350 mild
   250-350 moderate
   \<250 severe
  ------------------------------------------------------------------------

A pan-diastolic back flow in descending aorta using suprasternal view indicates more than moderate regurgitation

Aortic valve implantation {#sec2-4}
-------------------------

Mentice aortic valve implantation is designed for interventional cardiologists and cardiac/cardiothoracic surgeons who wish to start training on transcatheter aortic valve implantation/TAVR (TAVI/TAVR). The module allows for safe and cost-effective training for individual instruction or as part of a hospital quality improvement or change-of-process program \[[Figure 10](#F10){ref-type="fig"}\].

![The module allows for safe and cost-effective training](ACA-19-498-g010){#F10}

This module assumes familiarity with preoperative computed tomography imaging, echocardiography and extensive experience with endovascular intervention, and cardiac catheterization. Both balloon- and self-expandable valve types are supported, which facilitates a discussion on pros and cons, as well as to understand the differences in deployment technique. The stepwise approach, where each step of the procedure is carried out in a safe, simulated environment, prepares the trainee to meet unexpected events in the operating room. Together with a VIST^®^-C extension, the module can be run with bifemoral access to further enhance training realism.

An ideal platform for the following reasons is required:

Teaching patient selection and preoperative planningTraining of TAVI/TAVR in a stepwise approachManaging and minimizing radiation dose exposureTraining of required technical and manipulation skillsReview, validation, and amendment of the procedure plan.

Aortic valve implantation is designed for understanding and learning the critical steps involved in the complex high-risk procedure of TAVI/TAVR.

Infective endocarditis-aortic valve {#sec2-5}
-----------------------------------

IE involving the AV occurs either on a pre-existing rheumatic or bicuspid aortic valve disease. However, a normal valve IE is also fairly common. The echocardiographic hallmark of IE is a mobile-oscillating nodular, linear, or shaggy echo density on involving either one or more aortic valve cusps. Varying grades of AR are usually seen in such patients. Sub-acute or chronic complications include ring or annular abscess, pseudo aneurysm of the ascending aorta, aorta to the left atrium/right ventricle fistula, and flail aortic leaflets \[[Figure 11](#F11){ref-type="fig"}\]. TTE has sensitivity and specificity of 65--70% in detecting vegetation.\[[@ref5][@ref6]\] If a strong clinical suspicion for IE exists in a patient with a negative TTE study, TEE should be suggested, which has a much higher predictive accuracy (more than 90%).

![Aortic valve vegetation (shaggy, fluffy echo densities). (photo courtesy by CAE-DSS Imagetech)](ACA-19-498-g011){#F11}

Aortic stenosis and mitral stenosis Doppler {#sec2-6}
-------------------------------------------

Flow velocity has been added to the existing AS and mitral stenosis models (pathology module 2). Spectral and color flow Doppler demonstrates characteristic appearances with stenotic flow \[[Figure 12](#F12){ref-type="fig"}\].\[[@ref9][@ref10]\]

![Transesophageal echocardiogram image of mitral stenosis with Doppler](ACA-19-498-g012){#F12}

CONCLUSION {#sec1-11}
==========

Accurate patient-specific AR models including the vessel wall thickness and calcification deposits represent a useful tool to guide TAVR and to help in preventing the migration of the valve during the deployment procedure. In addition, optimizing the positioning of the valve during deployment, as well as alternative approaches to TAVR valves tailored to patient\'s specific pathology, for example, polymeric valves, may offer better procedural outcome. Future research should focus on collaborative efforts to validate previously identified predictors and to explore the role of others, and well-designed large-scale studies that include different devices should focus on long-term clinical outcomes. Given the clinical and economic impact of such interventions,\[[@ref7][@ref8]\] clinicians should appropriately risk stratify patients. Well-established predictors can be useful tools to guide clinical decision-making before and after TAVR (appropriate device selection and decision for permanent pacing, respectively), and subsequently improve the clinical outcomes.
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